Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Mov Disord. 2012 Nov 9;28(2):176–182. doi: 10.1002/mds.25247

Table 2.

Mean patella and tibia bone lead concentrations by key characteristics of participants with Parkinson’s disease in the study of lead exposure and cognition.

Characteristic Patella bone lead
Tibia bone lead
N (%)a Mean concentration (sd), μg/g bone P value N (%)a Mean concentration (sd), μg/g bone P value
Age at cognitive interview 0.01 0.5
 54.0–64.9 20 (20%) 6.3 (11.5) 20 (20%) 5.1 (11.5)
 65.0–69.9 35 (36%) 11.1 (7.1) 35 (35%) 9.3 (10.9)
 70.0–74.9 24 (24%) 6.6 (10.3) 25 (25%) 7.1 (8.4)
 75.0–80.9 19 (19%) 14.7 (10.2) 21 (21%) 8.8 (11.8)
Sex 0.2 0.9
 Female 44 (45%) 8.4 (10.2) 45 (45%) 8.0 (10.5)
 Male 54 (55%) 10.8 (9.7) 56 (55%) 7.7 (10.8)
Race 0.7 >0.9
 White 88 (87%) 9.4 (10.1) 88 (87%) 7.9 (10.9)
 Other 5 (5%) 9.4 (5.1) 5 (5%) 7.8 (9.4)
 Missing 8 (8%) 12.7 (10.2) 8 (8%) 6.7 (8.5)
Educational attainment 0.2 0.04
 Up through high school 19 (19%) 11.6 (10.3) 19 (19%) 9.9 (9.1)
 Associate’s degree 12 (12%) 10.2 (10.7) 12 (12%) 10.9 (11.5)
 Bachelor’s degree 28 (29%) 11.8 (8.8) 29 (29%) 10.4 (12.5)
 Master’s or doctoral degree 39 (40%) 7.1 (10.0) 41 (41%) 4.2 (8.7)
Smoking history 0.004 0.07
 Never smoked 58 (59%) 6.8 (9.0) 59 (58%) 6.2 (10.8)
 Ever smoked 40 (40%) 13.8 (9.7) 42 (42%) 10.1 (10.1)
By doseb 0.001 0.2
 < 20 pack-years 30 (75%) 12.7 (9.5) 32 (76%) 9.7 (10.4)
 20+ pack-years 10 (25%) 17.3 (10.1) 10 (24%) 11.3 (9.3)
Age of PD symptom onset 0.3 0.7
 35.0–54.9 12 (19%) 7.5 (13.3) 12 (18%) 9.4 (12.0)
 55.0–64.9 30 (48%) 7.9 (8.4) 31 (47%) 6.5 (11.1)
 65.0–78.9 21 (33%) 12.1 (10.7) 23 (35%) 7.6 (10.7)
a

Percentages are of the number of participants with valid data on the bone lead measure and characteristic.

b

Percentages shown are among ever smokers.